Cancer: RNA-based approaches target KRAS
Nature Reviews Drug Discovery 16, 529 (2017).
doi:10.1038/nrd.2017.137
Author: Sarah Crunkhorn
Activating mutations in the KRAS oncogene commonly occur in human tumours and are associated with cancer initiation, metastasis and poor prognosis. Despite significant effort, direct and specific therapeutic targeting of KRAS has so far proved elusive. Two new papers now report the use
Source: Nature Reviews Drug Discovery - Category: Drugs & Pharmacology Authors: Sarah Crunkhorn Tags: Research Highlight Source Type: research